Last updated: January 17, 2018
Sponsor: Grupo de Estudos Multicentricos em Onco-Hematologia
Overall Status: Completed
Phase
3
Condition
Effects Of Chemotherapy
Multiple Myeloma
Bone Neoplasm
Treatment
N/AClinical Study ID
NCT03402295
GBRAM003r
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- multiple myeloma newly diagnose elegible to autologous transplantation Patientssubmitted to ctd or vcd Myeloma patients newly diagnose >18yo
Exclusion
Exclusion Criteria:
- other chemotherapy induction protocol
Study Design
Total Participants: 311
Study Start date:
June 15, 2009
Estimated Completion Date:
October 15, 2017